Cystatin C at Admission in the Intensive Care Unit Predicts Mortality among Elderly Patients

Maria Aparecida Dalboni1, Daniel de Oliveira Beraldo1, Beata Marie Redublo Quinto1

  • 1Universidade Federal de São Paulo, Botucatu Street, n740, Vila Clementino, 04023-062 São Paulo, SP, Brazil.

ISRN Nephrology
|June 27, 2014
PubMed

Insights

Serum cystatin C levels in elderly intensive care unit (ICU) patients do not predict acute kidney injury (AKI). However, elevated cystatin C independently predicts mortality, serving as a marker of poor prognosis in this population.

Area of Science:

  • Nephrology
  • Critical Care Medicine
  • Geriatrics

Background:

  • Serum cystatin C is utilized in critical care to assess renal function.
  • Previous studies suggest a correlation between cystatin C and mortality.
  • The precise mechanism linking cystatin C to mortality, whether via acute kidney injury (AKI) or other factors, remains unclear.

Purpose of the Study:

  • To determine if serum cystatin C levels upon intensive care unit (ICU) admission predict AKI in elderly patients.
  • To evaluate whether serum cystatin C predicts mortality in elderly ICU patients.
  • To compare the predictive value of cystatin C versus AKI for mortality.

Main Methods:

  • Prospective study involving elderly ICU patients without AKI at admission.
  • Serum cystatin C levels were measured at ICU entry for 234 selected patients.
  • Development of AKI and mortality were monitored; statistical analyses included ROC curves and hazard ratios.

Main Results:

  • Higher serum cystatin C levels did not predict the development of AKI (P = 0.1).
  • Serum cystatin C was an independent predictor of mortality (Hazard Ratio = 6.16, P = 0.01).
  • AKI was not associated with death, while cystatin C showed a moderate predictive area for mortality (0.67, P = 0.03).

Conclusions:

  • Elevated serum cystatin C levels are an independent predictor of mortality in elderly ICU patients.
  • Serum cystatin C may serve as a valuable marker for poor prognosis in this patient group.
  • The association of cystatin C with mortality appears independent of acute kidney injury.

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
655
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
557
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
352
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
677
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
2.9K